Northern Trust Company of Connecticut’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
$86.8M Buy
1,027,716
+9,480
+0.9% +$750K 0.54% 15
2013
Q3
$78.5M Buy
1,018,236
+146,128
+17% +$10.2M 0.51% 17
2013
Q2
$51M Buy
+872,108
New +$52.5M 0.35% 44

Other funds holding CELG

Northern Trust Company of Connecticut's CELG Position: Q4 2013 in Review

Northern Trust Company of Connecticut increased its Celgene Corp (CELG) stake by 0.93% in Q4 2013, buying an estimated $750K and bringing the position to 1,027,716 shares worth $86.8M. The position accounts for 0.54% of the portfolio, ranked #15.

Northern Trust Company of Connecticut first reported a position in CELG in Q2 2013 and has held it in 3 quarters since. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • Northern Trust Company of Connecticut held 1,027,716 shares of Celgene Corp worth $86.8M as of Q4 2013.
  • Northern Trust Company of Connecticut bought 9,480 Celgene Corp shares in Q4 2013, an estimated $750K.
  • Celgene Corp made up 0.54% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #15 holding.
  • Northern Trust Company of Connecticut first reported a position in Celgene Corp in Q2 2013 and has held it in 3 quarters since.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.